Image

An App-based Instructional Platform to Improve Eye Drop Recall

An App-based Instructional Platform to Improve Eye Drop Recall

Not Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens.

Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule.

At one month, both groups will be assessed on their eye drop regimen recall.

Description

Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period.

App features

  1. Pictorial representation of drops (color-coded) and schedule.
  2. Quiz to assess understanding of the regimen.
  3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop.
  4. Graphical print-out of the regimen.

Study design

  1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app.
  2. Study population:

Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops

Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops

3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops.

4. Main outcome measure: Ability to correctly identify drops/regimen

Eligibility

Inclusion Criteria:

  • patients with a diagnosis of glaucoma (any type)
  • drop regimen of at least 2 pressure-lowering drops
  • languages supported at this time: English, Spanish, Cantonese

Exclusion Criteria:

  • concurrent eye conditions necessitating additional eye drops
  • inability to self-administer eye drops
  • inability to engage with app (either visual or other barrier)

Study details
    Glaucoma

NCT06045390

University of California, San Francisco

21 November 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.